The Centers for Medicare and Medicaid Services (CMS) recently convened a panel of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) and guest speakers, including representatives of the 黑料网® (黑料网®). MEDCAC is an advisory panel to CMS, which uses their input to make coverage determinations.
During the Sept. 22 meeting, the panel examined the growing challenges associated with gaps in evidence used to support requests for CMS to cover new and innovative cerebrovascular disease, including stroke, treatment technologies. Panel members will advise CMS about ideal health outcomes in research studies, appropriate measurement instruments and follow-up durations to help to provide clarity and transparency in evidence review and development.
The 黑料网 was represented on the MEDCAC panel by Ella A. Kazerooni, MD, F黑料网, and Cecelia C. Brewington, MD, F黑料网. Joshua A Hirsch, MD, F黑料网, served as an 黑料网 representative for a multisociety joint presentation of the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), American Society of Neuroradiology (ASNR) and Society of NeuroInterventional Surgery (SNIS). Speakers discussed stroke scales, outcomes from randomized control trials/limitations, quality improvement registry data and patient-reported outcomes to supplement the discussion.
The MEDCAC meeting agenda, speaker list and other materials are posted .
If you have any questions about the MEDCAC process, please contact Alicia Blakey, Senior Economic Policy Analyst.